In the News
NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma
Read More
Monte Rosa
Latest News
All
- In the News
- Press Releases
- Scientific Publications
Press Releases
Monte Rosa Therapeutics Announces Pricing of Initial Public Offering
Read More
Press Releases
Monte Rosa Therapeutics Expands Leadership Team with Appointment of Filip Janku, M.D., Ph.D., as Chief Medical Officer
Read More
Press Releases
Monte Rosa Therapeutics Announces $95 Million Series C Financing to Accelerate Next-generation Protein Degradation Platform
Read More
Press Releases
Monte Rosa Therapeutics Strengthens Leadership with Key Executive and Board Appointments
Read More
Press Releases
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Read More
Press Releases
Monte Rosa Therapeutics Expands Senior Management Team
Read More
Press Releases
Monte Rosa Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
Read More
Press Releases
Monte Rosa Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference
Read More
Press Releases
Monte Rosa Therapeutics Announces Formation of Scientific Advisory Board
Read More
Press Releases
Monte Rosa Therapeutics Strengthens Executive Leadership Team with New Appointments
Read More
Press Releases
Monte Rosa Therapeutics Announces $96 Million Series B Financing to Advance Small Molecule-based Protein Degradation Platform
Read More
Press Releases
Monte Rosa exits stealth mode with $32.5 million Series A commitment from Versant Ventures and NEA
Read More
Are you ready to take
your career to new heights?
Are you ready to take
your career to new heights?
We’re looking for enthusiastic and energetic candidates ready to level up in their career and take the path less travelled. Sound like you? Clip in. We are tackling seemingly insurmountable challenges, fearlessly.